The update interpretation of 2020 EAU prostate cancer guideline(Part Ⅰ)
10.3760/cma.j.cn112330-20200518-00397
- VernacularTitle:2020版EAU前列腺癌指南更新解读之一
- Author:
Yu FAN
1
;
Zhisong HE
Author Information
1. 北京大学第一医院泌尿外科 北京大学泌尿外科研究所 国家泌尿男生殖系肿瘤中心 100034
- From:
Chinese Journal of Urology
2020;41(5):330-331
- CountryChina
- Language:Chinese
-
Abstract:
The update of active surveillance section in European Association of Urology guidelines 2020 edition mainly referred the DETECTIVE consensus, which was first published in 2019 on the European Journal of Urology. The content of update was outlined as follows: ①Pathologically, patients with qualified ISUP 1 and 2 can be selected for active surveillance, and excluded pathological types are also listed; ②The guideline emphasizes the important role of MRI in active surveillance, in confirmatory biopsy, monitoring process and withdrawal; ③Emphasizing the role of PSA velocity and PSA doubling time in the monitoring process and withdrawal.
